A New Theranostic Platform Against Gram‐Positive Bacteria Based on Near‐Infrared‐Emissive Aggregation‐Induced Emission Nanoparticles
Abstract
Infections induced by Gram‐positive bacteria pose a great threat to public health. Antibiotic therapy, as the first chosen strategy against Gram‐positive bacteria, is inevitably associated with antibiotic resistance selection. Novel therapeutic strategies for the discrimination and inactivation of Gram‐positive bacteria are thus needed. Here, a specific type of aggregation‐induced emission luminogen (AIEgen) with near‐infrared fluorescence emission as a novel antibiotic‐free therapeutic strategy against Gram‐positive bacteria is proposed. With the combination of a positively charged group into a highly twisted architecture, self‐assembled AIEgens (AIE nanoparticles (NPs)) at a relatively low concentration (5 µm) exhibited specific binding and photothermal effect against living Gram‐positive bacteria both in vitro and in vivo. Moreover, toxicity assays demonstrated excellent biocompatibility of AIE NPs at this concentration. All these properties make the AIE NPs as a novel generation of theranostic platform for combating Gram‐positive bacteria and highlight their promising potential for in vivo tracing of such bacteria.Keywords
Funding Information
- National Key Research and Development Program of China (2021YFE0108300, 2022YFE0118000)
- National Natural Science Foundation of China (82001075)
This publication has 41 references indexed in Scilit:
- Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteriaNanomedicine: Nanotechnology, Biology and Medicine, 2014
- Which antibiotic for resistant Gram-positives, and why?Journal of Infection, 2014
- Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agentsCurrent Opinion in Microbiology, 2010
- The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnessesBMJ, 2010
- Differentiation of Staphylococcus aureus strains by CE, zeta potential and coagulase gene polymorphismElectrophoresis, 2009
- Update on Bacterial Conjunctivitis in South FloridaOphthalmology, 2008
- Antibacterial resistance worldwide: causes, challenges and responsesNature Medicine, 2004
- Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- The control of gut motilityComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2001
- Modulation of peristalsis in the guinea‐pig isolated small intestine by exogenous and endogenous opioidsBritish Journal of Pharmacology, 1992